Deferoxamine mesylate inhibits bacterial growth in vivo.

Y. Ando, T. Akaike, M. Inoue, Y. Horisawa, Y. Yamada, K. Uekawa, R. Fujise, S. Araki

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Iron is one of the essential element for bacterial growth. To study the effect of chelation of iron on bacterial growth, 17 different strains of bacteria were cultured in chocolate-agar medium in the presence or absence of deferoxamine methylate (DM), a potent chelating agent for iron. A fairly low concentration of DM (10 mg/ml) in the culture medium markedly inhibited the growth rates of the three bacterial strains, B. catarrhalis, N. meningiditis and N. gonorrhoeae. In vivo effect of DM was also tested in mice that were intraperitoneally inoculated with a lethal number of N. meningiditis (2 x 10(8)/animal). After 40 h of inoculation, more than 90% of the control animals died for acute peritonitis. In contrast, animals which were intraperitoneally administered with DM showed a marked resistance to the inoculated bacteria without showing toxic effects of the agent: less than 30% of animals died of acute peritonitis caused by infection within 40 h. The results suggest that, in addition to the currently used antibiotics. DM might also be an useful therapeutic agent for treatment of bacterial infection.

Original languageEnglish
Pages (from-to)207-212
Number of pages6
Journal[Hokkaido igaku zasshi] The Hokkaido journal of medical science
Volume63
Issue number2
Publication statusPublished - 1988 Mar
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Deferoxamine mesylate inhibits bacterial growth in vivo.'. Together they form a unique fingerprint.

Cite this